» Articles » PMID: 22137794

VCAM-1 Promotes Osteolytic Expansion of Indolent Bone Micrometastasis of Breast Cancer by Engaging α4β1-positive Osteoclast Progenitors

Overview
Journal Cancer Cell
Publisher Cell Press
Specialty Oncology
Date 2011 Dec 6
PMID 22137794
Citations 290
Authors
Affiliations
Soon will be listed here.
Abstract

Breast cancer patients often develop locoregional or distant recurrence years after mastectomy. Understanding the mechanism of metastatic recurrence after dormancy is crucial for improving the cure rate for breast cancer. Here, we characterize a bone metastasis dormancy model to show that aberrant expression of vascular cell adhesion molecule 1 (VCAM-1), in part dependent on the activity of the NF-κB pathway, promotes the transition from indolent micrometastasis to overt metastasis. By interacting with the cognate receptor integrin α4β1, VCAM-1 recruits monocytic osteoclast progenitors and elevates local osteoclast activity. Antibodies against VCAM-1 and integrin α4 effectively inhibit bone metastasis progression and preserve bone structure. These findings establish VCAM-1 as a promising target for the prevention and inhibition of metastatic recurrence in bone.

Citing Articles

Integrins identified as potential prognostic markers in osteosarcoma through multi-omics and multi-dataset analysis.

Cui L, Zhao S, Teng H, Yang B, Liu Q, Qin A NPJ Precis Oncol. 2025; 9(1):19.

PMID: 39825088 PMC: 11742673. DOI: 10.1038/s41698-024-00794-5.


Secreted LGALS3BP facilitates distant metastasis of breast cancer.

Kim S, Park I, Kim J, Ka N, Lim G, Park M Breast Cancer Res. 2025; 27(1):4.

PMID: 39789641 PMC: 11715970. DOI: 10.1186/s13058-024-01958-8.


Cancer Cells in Sleep Mode: Wake Them to Eliminate or Keep Them Asleep Forever?.

Liu W, Kovacs A, Hou J Cells. 2024; 13(23).

PMID: 39682769 PMC: 11640528. DOI: 10.3390/cells13232022.


CMTM7 shapes the chronic inflammatory and immunosuppressive tumor microenvironment in hepatocellular carcinoma as an M2 macrophage biomarker.

Zhu Z, Liu H, Fu H, Luo Y, Chen B, Wu X Sci Rep. 2024; 14(1):29659.

PMID: 39609464 PMC: 11604762. DOI: 10.1038/s41598-024-75538-3.


CD8 + T-Cell-Related Genes: Deciphering Their Role in the Pancreatic Adenocarcinoma TME and Their Effect on Prognosis.

Zhang Y, Hou H, Zhang X, Lan H, Huo X, Duan X Dig Dis Sci. 2024; 70(1):262-284.

PMID: 39604668 DOI: 10.1007/s10620-024-08715-z.


References
1.
Carter R, Wicks I . Vascular cell adhesion molecule 1 (CD106): a multifaceted regulator of joint inflammation. Arthritis Rheum. 2001; 44(5):985-94. DOI: 10.1002/1529-0131(200105)44:5<985::AID-ANR176>3.0.CO;2-P. View

2.
Goss P, Chambers A . Does tumour dormancy offer a therapeutic target?. Nat Rev Cancer. 2010; 10(12):871-7. DOI: 10.1038/nrc2933. View

3.
Zhang X, Wang Q, Gerald W, Hudis C, Norton L, Smid M . Latent bone metastasis in breast cancer tied to Src-dependent survival signals. Cancer Cell. 2009; 16(1):67-78. PMC: 2749247. DOI: 10.1016/j.ccr.2009.05.017. View

4.
Hu G, Chong R, Yang Q, Wei Y, Blanco M, Li F . MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer. Cancer Cell. 2008; 15(1):9-20. PMC: 2676231. DOI: 10.1016/j.ccr.2008.11.013. View

5.
Lurquin C, De Smet C, Brasseur F, Muscatelli F, Martelange V, De Plaen E . Two members of the human MAGEB gene family located in Xp21.3 are expressed in tumors of various histological origins. Genomics. 1998; 46(3):397-408. DOI: 10.1006/geno.1997.5052. View